Citation: A. Furstner et al., Exploiting the reversibility of olefin metathesis. Syntheses of macrocyclic trisubstituted alkenes and (R,R)-(-)-pyrenophorin, ORG LETT, 3(3), 2001, pp. 449-451
Citation: L. Ackermann et al., Ruthenium carbene complexes with imidazol-2-ylidene ligands: Syntheses of conduritol derivatives reveals superior RCM activity, TETRAHEDRON, 56(15), 2000, pp. 2195-2202
Authors:
Furstner, A
Thiel, OR
Ackermann, L
Schanz, HJ
Nolan, SP
Citation: A. Furstner et al., Ruthenium carbene complexes with N,N '-bis(mesityl) imidazol-2-ylidene ligands: RCM catalysts of extended scope, J ORG CHEM, 65(7), 2000, pp. 2204-2207
Citation: L. Ackermann et W. Kulisch, Investigation of diamond etching and growth by in situ scanning tunneling microscopy, DIAM RELAT, 8(7), 1999, pp. 1256-1260
Authors:
Ackermann, L
Heidbreder, A
Wurche, F
Klarner, FG
Mattay, J
Citation: L. Ackermann et al., Mechanistic studies on PET-oxidative cyclization of unsaturated silyl enolethers: dependence of the regioselectivity on alcohol addition and pressure effects, J CHEM S P2, (4), 1999, pp. 863-869
Authors:
Ackermann, L
Furstner, A
Weskamp, T
Kohl, FJ
Herrmann, WA
Citation: L. Ackermann et al., Ruthenium carbene complexes with imidazolin-2-ylidene ligands allow the formation of tetrasubstituted cycloalkenes by RCM, TETRAHEDR L, 40(26), 1999, pp. 4787-4790
Authors:
Harvima, IT
Haapanen, L
Ackermann, L
Naukkarinen, A
Harvima, RJ
Horsmanheimo, M
Citation: It. Harvima et al., Decreased chymase activity is associated with increased levels of proteaseinhibitors in mast cells of psoriatic lesions, ACT DER-VEN, 79(2), 1999, pp. 98-104